About ICR
Institute for Cannabinoid Research (ICR) is a cross-disciplinary organization bringing together researchers, clinicians, and scientists from around the world. Its mission is to foster international collaboration and advance scientific understanding of cannabinoids and the endocannabinoid system.
The institute engages in research, development, education, consulting, and public awareness initiatives, contributing to both scientific literature and evidence-based clinical practices.
Executive Scientific Advisory Council on Projects and International Affairs
Our Scientific Council includes globally recognized experts in biochemistry, molecular biology, neurotoxicology, physiology, and translational medicine. Their expertise guides ICR’s scientific direction and ensures the highest standards of research integrity.
Dr Dale Deutsch – Pioneer in endocannabinoid biology and FABP transport
Dr Jennifer Pluznick – Discoverer of functional olfactory receptors in the kidney
Dr Michael Aschner – Leading authority in neurotoxicology
Dr Clovis Orlando Pereira da Fonseca – pioneer for inhalational chemotherapy with the terpene perillyl alcohol in glioblastoma
Dr Kevin Wildenhaus –Behavioral Science Lead, Janssen World Without Disease Accelerator
Dr ErhanYarar – Translational medicine expert; Chief Clinician in Differential Diagnosis at ICR
Dr Mahir Yıldırım – recognized pioneer in chemosaturation and LIOX therapy
